Evolent Health, Inc.

Equities

EVH

US30050B1017

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 03:08:10 2024-04-25 pm EDT			5-day change	1st Jan Change
28.14 ^USD	-3.83%		-4.36%	-14.23%

Apr. 22	Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target	MT
Mar. 28	Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating	MT

Evolent Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022

May 04, 2022 at 04:15 pm EDT

Evolent Health, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 297.06 million compared to USD 215.07 million a year ago. Net loss was USD 5.35 million compared to USD 9.81 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.13 a year ago. Basic loss per share was USD 0.06 compared to USD 0.12 a year ago.

Latest news about Evolent Health, Inc.

Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target	Apr. 22	MT
Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating	Mar. 28	MT
JPMorgan Trims Price Target on Evolent Health to $52 From $53, Maintains Overweight Rating	Mar. 15	MT
Transcript : Evolent Health, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 02:35 PM	Mar. 12
Canaccord Genuity Cuts Price Target on Evolent Health to $45 From $47, Maintains Buy Rating	Feb. 23	MT
Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours	Feb. 22	MT
Transcript : Evolent Health, Inc., Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 EPS $0.23, vs. Street Est of $0.15	Feb. 22	MT
Earnings Flash (EVH) EVOLENT HEALTH Posts Q4 Revenue $556.1M, vs. Street Est of $542.9M	Feb. 22	MT
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	Feb. 22	CI
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
Evolent Health, Inc. Announces Board Changes	Feb. 14	CI
Transcript : Evolent Health, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 03:45 PM	Jan. 09
JMP Securities Initiates Evolent Health With Market Outperform Rating, Price Target is $37	Dec. 06	MT
Evolent Health Plans $350 Million Convertible Senior Notes Offering; Shares Fall	Dec. 05	MT
Evolent Health Shares Drop on $350 Million Note Offering	Dec. 05	DJ
RBC Trims Price Target on Evolent Health to $42 From $44, Keeps Outperform Rating	Nov. 28	MT
Truist Securities Trims Price Target on Evolent Health to $34 From $36, Maintains Hold Rating	Nov. 14	MT
Transcript : Evolent Health, Inc., Q3 2023 Earnings Call, Nov 02, 2023	Nov. 02
Earnings Flash (EVH) EVOLENT HEALTH Posts Q3 EPS $0.30	Nov. 02	MT
Earnings Flash (EVH) EVOLENT HEALTH Reports Q3 Revenue $511M, vs. Street Est of $509.8M	Nov. 02	MT
Evolent Health, Inc. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2023 and Full Year 2023	Nov. 02	CI
Evolent Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
UBS Starts Evolent Health With Buy Rating, Price Target is $46	23-10-16	MT
Insider Sell: Evolent Health	23-08-17	MT

Chart Evolent Health, Inc.

Duration

Period

More charts

Company Profile

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-09 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Evolent Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

29.26 USD

Average target price

44.86 USD

Spread / Average Target

+53.31%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

	1st Jan change	Capi.
EVOLENT HEALTH, INC.	-14.23%	3.33B
VEEVA SYSTEMS INC.	+3.09%	32.41B
PRO MEDICUS LIMITED	+12.62%	7.31B
SECTRA AB	+20.38%	3.85B
OMNICELL, INC.	-28.51%	1.26B
LUNIT INC.	-34.43%	1.12B
SIMULATIONS PLUS, INC.	+1.47%	932M
VERADIGM INC.	-24.79%	864M
B-SOFT CO.,LTD.	-38.47%	863M
SURGICAL SCIENCE SWEDEN AB	-22.63%	702M

Medical Software & Technology Services